Kidney Res Clin Pract > Volume 32(3); 2013 > Article |
|
Hemodialysis (n=15) |
On-line hemodiafiltration (n=11) |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Baseline | 6 mo | 12 mo | 18 mo | 24 mo | Baseline | 6 mo | 12 mo | 18 mo | 24 mo | |
Hemoglobin (g/dL) | 10.0±1.2 | 10.0±1.0 | 10.1±1.3 | 9.4±1.1 | 9.8±0.6 | 9.1±1.2 | 9.6±1.3 | 10.3±1.3 | 10.4±0.6* | 10.2±0.9 |
Calcium (mg/dL) | 8.2±0.6 | 8.2±0.8 | 8.5±0.9 | 8.4±0.6 | 8.0±0.7 | 8.9±1.4 | 8.4±0.7 | 8.4±0.6 | 8.2±0.9 | 8.2±0.8 |
Phosphorus (mg/dL) | 4.9±1.8 | 6.0±1.8 | 5.1±1.9 | 4.3±1.3 | 5.2±2.0 | 4.5±1.4 | 4.7±1.0* | 4.2±1.4 | 4.7±1.2 | 5.1±1.7 |
Glucose (mg/dL) | 190.6±67.5 | 180.8±65.7 | 142.9±51.7 | 161.0±56.0 | 159.3±74.3 | 143.0±83.0 | 156.8±65.3 | 139.1±39.1 | 131.3±39.3 | 120.3±38.2 |
BUN (mg/dL) | 50.5±17.0 | 60.1±17.8 | 66.5±19.1 | 61.2±23.5 | 69.9±18.6 | 58.6±18.1 | 48.4±14.4 | 56.0±11.5 | 68.3±23.8 | 56.9±17.9 |
Creatinine (mg/dL) | 8.4±2.1 | 9.1±2.6 | 9.6±3.3 | 9.7±2.0 | 10.1±1.9 | 9.2±2.5 | 8.5±3.0 | 8.8±2.5 | 9.9±3.0 | 9.9±2.9 |
Uric acid (mg/dL) | 6.5±1.0 | 6.6±1.3 | 7.2±1.4 | 7.2±1.6 | 7.8±1.5 | 6.9±1.5 | 6.6±0.8 | 7.0±0.8 | 7.9±1.7 | 7.6±1.5 |
Total cholesterol (mg/dL) | 154.4±34.7 | 149.5±24.3 | 155.0±58.9 | 143.6±38.1 | 147.6±38.9 | 137.0±26.9 | 126.1±23.0 | 125.9±33.0 | 130.3±21.3 | 121.2±24.3 |
Albumin (g/dL) | 3.5±0.4 | 3.7±0.4 | 3.7±0.2 | 3.5±0.5 | 3.6±0.4 | 3.3±0.5 | 3.3±0.5* | 3.6±0.4 | 3.5±0.3 | 3.5±0.5 |
Triglyceride (mg/dL) | 120.5±50.4 | 147.3±89.4 | 103.6±57.9 | 72.7±27.4 | 91.4±4v3.4 | 136.8±92.4 | 114.1±34.3 | 94.4±32.4 | 114.3±32.2* | 86.3±22.5 |
HDL-cholesterol (mg/dL) | 40.4±12.5 | 37.3±12.0 | 37.8±14.6 | 37.8±13.8 | 38.4±7.9 | 32.9±6.5 | 29.6±4.1 | 32.7±7.6 | 30.7±4.3 | 30.2±4.6 |
Na (mEq/L) | 139.3±2.9 | 139.3±3.2 | 140.3±3.3 | 140.8±3.9 | 138.5±2.7 | 141.2±4.1 | 140.1±2.0 | 141.3±2.4 | 139.2±2.6 | 141.3±2.3 |
K (mEq/L) | 4.7±1.0 | 4.9±0.7 | 5.0±1.7 | 5.3±0.8 | 5.4±0.7 | 4.7±1.3 | 4.9±1.1 | 5.1±0.9 | 5.2±0.9 | 5.0±0.8 |
Cl (mEq/L) | 97.5±3.4 | 88.3±30.5 | 101.7±4.1 | 99.3±2.6 | 101.4±1.7 | 99.0±4.8 | 100.3±13.9 | 100.0±2.5 | 101.3±4.3 | 99.2±2.0 |
Total CO2 (mEq/L) | 22.9±2.2 | 22.6±3.6 | 21.2±3.8 | 20.6±3.1 | 21.8±2.6 | 23.9±2.9 | 23.0±1.3 | 23.4±1.7 | 22.3±3.3 | 23.5±3.4 |
β2-MG (mg/dL) | 34.6±16.3 | 32.3±8.6 | 31.7±5.9 | 33.4±13.4 | 37.3±9.1 | 33.4±15.2 | 25.9±8.5*,† | 26.3±6.0*,† | 26.9±9.2*,† | 28.4±6.2*,† |
PTH (pg/mL) | 176.3±97.3 | 193.8±39.1 | 188.0±148.1 | 151.4±134.9 | 198.4±114.6 | 190.8±87.6 | 141.5±53.6 | 265.0±219.1 | 224.9±182.1 | 220.2±278.8 |
CRP (mg/dL) | 0.6±0.9 | 0.6±0.8 | 0.5±0.7 | 0.8±1.6 | 0.6±1.1 | 1.1±1.6 | 1.7±0.9 | 0.4±0.4 | 0.5±0.6 | 0.5±0.8 |
Kt/V | 1.2±0.4 | 1.3±0.9 | 1.3±0.8 | 1.3±1.4 | 1.3±1.2 | 1.2±0.5 | 1.3±0.8 | 1.4±0.9 | 1.3±0.9 | 1.3±1.3 |
Hemodialysis (n=15) | On-line hemodiafiltration (n=11) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Baseline | 6 mo | 12 mo | 18 mo | 24 mo | Baseline | 6 mo | 12 mo | 18 mo | 24 mo | |
|
||||||||||
Time-domain measures | ||||||||||
Mean NN (ms) | 817.1±149.2 | 833.3±142.1 | 860.4±140.1 | 811.0±213.4 | 756.8±76.1 | 822.5±159.2 | 843.8±159.0 | 803.8±165.8 | 796.7±107.5 | 989.5±60.1*,† |
SDNN (ms) | 110.7±30.3 | 96.0±27.9 | 96.9±27.4 | 98.1±46.2 | 67.0±23.7† | 93.9±30.6 | 94.5±24.7 | 84.0±16.7 | 82.7±30.1 | 100.0±24.0 |
Frequency-domain measures | ||||||||||
HF, ln (ms2) | 3.28±3.42 | 3.37±3.56 | 3.38±3.05 | 3.49±3.28 | 3.63±3.35† | 3.15±3.36 | 3.57±3.81*,† | 3.50±3.08* | 3.85±3.08*,† | 4.42±3.81*,† |
LF, ln(ms2) | 3.51±3.24 | 4.07±3.30† | 3.94±3.05† | 3.98±3.34† | 4.04±3.47† | 3.56±3.17 | 4.11±3.17* | 3.81±3.10 | 4.33±3.57*,† | 4.78±3.99*,† |
VLF, ln (ms2) | 4.78±4.65 | 5.07±5.29† | 5.10±4.72† | 5.03±4.96† | 4.42±4.82 | 4.90±4.62 | 5.31±5.04* | 5.36±4.86* | 5.73±5.49*,† | 6.38±5.54*,† |
LF/HF | 1.7±0.5 | 2.2±1.1 | 1.8±0.9v | 1.9±1.1 | 1.9±1.6 | 1.4±0.4 | 1.7±0.8 | 1.9±1.5 | 2.1±2.6*,† | 2.5±0.1*,† |
The impact of severe depression on the survival of older patients with end-stage kidney disease
The Effect of Hemodiafiltration on Improving the Skin Hyperpigmentation2008 September;27(5)
Outcomes of open heart surgery in patients with end-stage renal disease2019 September;38(3)